LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease

ID#: NCT04668898

Age: 30 years - 66+

Gender: All

Healthy Subjects: Accepts Healthy Volunteers

Recruitment Status: Recruiting

Start Date: April 29, 2019

End Date: March 01, 2024

Contact Information:
Maya Rawal, MS, CGC
212-844-8373
Deborah Raymond, MS
212-844-8713
Summary: Single site observational study focused on elucidating the genes and biochemical pathways involved in causing Parkinson disease.
Eligibility:

Inclusion Criteria:

- Parkinson disease patients and their family members and is limited to participants of Ashkenazi (Eastern European) Jewish descent with GBA and LRRK2 mutations, or with 3 or more family members with PD

- Participants must be local to the New York City area and willing to come to Mount Sinai Downtown for annual 2 hour study visits which include obtaining personal medical and family history information, blood, urine and spinal fluid samples, neurological exam and neuropsychiatric testing. Spinal fluid collection is encouraged but optional.

Exclusion Criteria: -Patients who do not have Parkinson disease or family members of Ashkenazi (Eastern European) Jewish descent who either has a GBA or LRRK2 mutations OR who has 3 or more family members with PD.
Find a Clinical Trial Find Cancer Clinical Trials